Circulating Tumour DNA for Minimal Residual Disease: Assay Sensitivity and the Decisions It Cannot Yet Support. (2023). Translational Medicine & Therapeutics Journal, 2(2), 110-119. https://doi.org/10.5281/zenodo.22649122